These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6167863)

  • 1. Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys.
    Schellekens H; de Reus A; Bolhuis R; Fountoulakis M; Schein C; Ecsödi J; Nagata S; Weissmann C
    Nature; 1981 Aug; 292(5825):775-6. PubMed ID: 6167863
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys.
    Schellekens H; van Eerd PM; de Reus A; Weck PK; Stebbing N
    Antiviral Res; 1982 Oct; 2(5):313-8. PubMed ID: 6817709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective antiviral prophylaxis with human interferons in a rhesus monkey model.
    Weimar W; Stitz LW; de Reus A; Schellekens H
    Transplant Proc; 1981 Mar; 13(1 Pt 1):528-30. PubMed ID: 6168051
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of human leukocyte interteron (HIF) on experimental viral keratitis in monkeys (author's transl)].
    SundmacheR ; Neumann-Haefelin D; Shrestha B
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Jul; 195(4):263-70. PubMed ID: 1080375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective antiviral prophylaxis and therapy by systemic application of human interferon in immunosuppressed monkeys.
    Neumann-Haefelin D; Shrestha B; Manthey KF
    J Infect Dis; 1976 Jun; 133 Suppl():A211-6. PubMed ID: 180202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial synthesis of a novel human leukocyte interferon.
    Yelverton E; Leung D; Weck P; Gray PW; Goeddel DV
    Nucleic Acids Res; 1981 Feb; 9(3):731-41. PubMed ID: 6164048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte interferon produced by E. coli is biologically active.
    Goeddel DV; Yelverton E; Ullrich A; Heyneker HL; Miozzari G; Holmes W; Seeburg PH; Dull T; May L; Stebbing N; Crea R; Maeda S; McCandliss R; Sloma A; Tabor JM; Gross M; Familletti PC; Pestka S
    Nature; 1980 Oct; 287(5781):411-6. PubMed ID: 6159538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeys.
    van der Meide PH; Harteveld N; Stebbing N; Schellekens H
    Antiviral Res; 1985; Suppl 1():199-207. PubMed ID: 3936413
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral activities of hybrids of two major human leukocyte interferons.
    Weck PK; Apperson S; Stebbing N; Gray PW; Leung D; Shepard HM; Goeddel DV
    Nucleic Acids Res; 1981 Nov; 9(22):6153-66. PubMed ID: 6171779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity.
    Nagata S; Taira H; Hall A; Johnsrud L; Streuli M; Ecsödi J; Boll W; Cantell K; Weissmann C
    Nature; 1980 Mar; 284(5754):316-20. PubMed ID: 6987533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At least three human type alpha interferons: structure of alpha 2.
    Streuli M; Nagata S; Weissmann C
    Science; 1980 Sep; 209(4463):1343-7. PubMed ID: 6158094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human leukocyte interferon produced in bacteria has antiproliferative activity.
    Evinger M; Maeda S; Pestka S
    J Biol Chem; 1981 Mar; 256(5):2113-4. PubMed ID: 6161932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the biological properties of plasmid and natural human interferons].
    Ovchinnikov IuA; Zhdanov VM; Solov'ev VD; Novokhatskiĭ AS; Aspetov RD
    Vopr Virusol; 1983; 28(1):14-21. PubMed ID: 6189294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and therapy of viral diseases with special reference to interferon].
    Neumann-Haefelin D
    Fortschr Med; 1977 Apr; 95(16):1093-4. PubMed ID: 192653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of a complex of poly(I). poly(C) and poly-l-lysine on the course of vaccinia in monkeys].
    Andzhaparidze OG; Bektemirov TA; Burgasova MP
    Vopr Virusol; 1977; (3):339-43. PubMed ID: 410162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis of a human leukocyte interferon gene.
    Edge MD; Green AR; Heathcliffe GR; Meacock PA; Schuch W; Scanlon DB; Atkinson TC; Newton CR; Markham AF
    Nature; 1981 Aug; 292(5825):756-62. PubMed ID: 6167861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synthesis of biologically active human leukocyte interferon directed by recombinant plasmid DNA.
    Weissbach H; Goeddel DV; McCandliss R; Maeda S; Familletti PC; Redfield B; Staehelin T; Pestka S
    Arch Biochem Biophys; 1981 Aug; 210(1):417-9. PubMed ID: 6170264
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of a chemically synthesized human alpha 1 interferon gene.
    De Maeyer E; Skup D; Prasad KS; De Maeyer-Guignard J; Williams B; Meacock P; Sharpe G; Pioli D; Hennam J; Schuch W; Atherton K
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4256-9. PubMed ID: 6181502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interferon-alpha 1 from E. coli on some cell functions.
    Masucci MG; Szigeti R; Klein E; Klein G; Gruest J; Montagnier L; Taira H; Hall A; Nagata S; Weissmann C
    Science; 1980 Sep; 209(4463):1431-5. PubMed ID: 6158096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.